An Element in the Bovine Papillomavirus Late 3' Untranslated Region Reduces Polyadenylated Cytoplasmic RNA Levels
Overview
Affiliations
Expression of the two bovine papillomavirus type 1 (BPV-1) late genes, L1 and L2, coding for the two capsid proteins, is limited to terminally differentiated keratinocytes in bovine fibropapillomas. This pattern of expression is determined both by the activity of the late promoter and by the inhibition of late region expression in less well differentiated cells. Inhibition of L1 and L2 mRNA production in nonpermissive cells must occur since the late region potentially could be transcribed from early region promoters. Nuclear runoff analysis of the late region has demonstrated that up to 95% of transcripts which are initiated in the early region in nonpermissive cells terminate within the late region upstream of the late polyadenylation site (C. C. Baker and J. Noe, J. Virol. 63:3529-3534, 1989). However, very few of the primary transcripts which include the late polyadenylation site are processed into mRNA. In this study, we have used expression vectors to characterize an inhibitory element active in nonpermissive cells which is located in the late 3' untranslated region (3'UTR). While the late polyadenylation site is functional in these cells, a 53-bp element in the late 3'UTR reduces levels of polyadenylated cytoplasmic RNA. This element inhibited chloramphenicol acetyltransferase (CAT) expression 6- to 10-fold when cloned in the sense orientation into the 3'UTR of a CAT expression vector. No block to expression was seen when the fragment was cloned immediately downstream of the poly(A) site, in an intron upstream of the CAT coding sequence, or in an antisense orientation in the 3'UTR. When the same fragment was deleted from a BPV-1 L1 expression vector, a sixfold increase in mRNA levels was seen. Actinomycin D chase experiments using BPV-1 L1 expression vectors indicated that the element does not destabilize cytoplasmic polyadenylated RNA. Therefore, the element must act before the mature mRNA reaches the cytoplasm. The data presented are consistent with effects on nuclear stability and/or inhibition of polyadenylation or nuclear transport.
Iamborwornkun N, Kitkumthorn N, Stevenson A, Kirk A, Graham S, Chuen-Im T Biomed Rep. 2024; 21(2):125.
PMID: 39006509 PMC: 11240274. DOI: 10.3892/br.2024.1813.
HPV and RNA Binding Proteins: What We Know and What Remains to Be Discovered.
Graham S Viruses. 2024; 16(5).
PMID: 38793664 PMC: 11126060. DOI: 10.3390/v16050783.
Let It Go: HIV-1 -Acting Repressive Sequences.
Ostermann P, Ritchie A, Ptok J, Schaal H J Virol. 2021; 95(15):e0034221.
PMID: 33980600 PMC: 8274598. DOI: 10.1128/JVI.00342-21.
Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.
Wu C, Kajitani N, Schwartz S Int J Mol Sci. 2017; 18(2).
PMID: 28208770 PMC: 5343901. DOI: 10.3390/ijms18020366.
The reciprocal regulation between splicing and 3'-end processing.
Kaida D Wiley Interdiscip Rev RNA. 2016; 7(4):499-511.
PMID: 27019070 PMC: 5071671. DOI: 10.1002/wrna.1348.